SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-9.04%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.19B
AUM Growth
+$1.19B
(-24%)
Cap. Flow
-$79.2M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
66.99%
Holding
79
New
10
Increased
12
Reduced
14
Closed
17
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$97.8M |
| 2 |
AstraZeneca
AZN
|
$36.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$24.8M |
| 4 |
Zoetis
ZTS
|
$20.1M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$19.7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$42.2M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$26.3M |
| 3 |
Align Technology
ALGN
|
$25.1M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$20.9M |
| 5 |
iRhythm Technologies
IRTC
|
$19.9M |
Sector Composition
| 1 | Healthcare | 98.59% |
